CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,133,000 | +5.3% | 63,109 | -27.1% | 0.02% | -5.0% |
| Q1 2021 | $2,025,000 | -18.1% | 86,577 | +0.8% | 0.02% | -28.6% |
| Q4 2020 | $2,473,000 | +101.5% | 85,856 | +41.7% | 0.03% | +55.6% |
| Q3 2020 | $1,227,000 | -28.5% | 60,573 | +6.1% | 0.02% | -21.7% |
| Q2 2020 | $1,715,000 | -25.0% | 57,068 | -21.6% | 0.02% | -34.3% |
| Q1 2020 | $2,288,000 | -28.1% | 72,788 | +7.7% | 0.04% | +40.0% |
| Q4 2019 | $3,184,000 | +859.0% | 67,578 | +31.3% | 0.02% | +733.3% |
| Q3 2019 | $332,000 | -49.9% | 51,461 | -4.7% | 0.00% | -40.0% |
| Q2 2019 | $663,000 | – | 54,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |